» Articles » PMID: 40056247

Prognostic Risk Modeling of Endometrial Cancer Using Programmed Cell Death-related Genes: a Comprehensive Machine Learning Approach

Overview
Journal Discov Oncol
Publisher Springer
Specialty Oncology
Date 2025 Mar 8
PMID 40056247
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endometrial cancer represents a significant health challenge, with rising incidence and complex prognostic challenges. This study aimed to develop a robust predictive model integrating programmed cell death-related genes and advanced machine learning techniques.

Methods: Utilizing transcriptomic data from TCGA-UCEC and GSE119041 datasets, we employed a comprehensive approach involving 117 machine learning algorithms. Key methodologies included differential gene expression analysis, weighted gene co-expression network analysis, functional enrichment studies, immune landscape evaluation, and multi-dimensional risk stratification.

Results: We identified 10 critical genes (PTGIS, TIMP3, SRPX, SNCA, HIC1, BAK1, STXBP2, TRIB3, RTKN2, E2F1) and constructed a prognostic model with superior predictive performance. The StepCox[forward] + plsRcox algorithm combination demonstrated excellent predictive accuracy (AUC > 0.8). Kaplan-Meier analysis revealed significant survival differences between high- and low-risk groups in both training (HR = 3.37, p < 0.001) and validation cohorts (HR = 2.05, p = 0.021). The model showed strong correlations with clinical characteristics, immune cell infiltration patterns, and potential therapeutic responses.

Conclusions: This study presents a novel, comprehensive approach to endometrial cancer prognosis, integrating machine learning and molecular insights to provide a more precise risk stratification tool with potential clinical translation.

References
1.
Shu Z, Du H, Zhu X, Ruan S, Li X . Research on the control strategies of data flow transmission paths for MPTCP-based communication networks. PeerJ Comput Sci. 2024; 9:e1716. PMC: 10773912. DOI: 10.7717/peerj-cs.1716. View

1.
Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang F, Villella J . Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer. 2003; 2:24. PMC: 156646. DOI: 10.1186/1476-4598-2-24. View

2.
Sandhu V, Bakkalci D, Wei S, Cheema U . Enhanced Biomimetics of Three-Dimensional Osteosarcoma Models: A Scoping Review. Cancers (Basel). 2024; 16(1). PMC: 10778420. DOI: 10.3390/cancers16010164. View

2.
Trnkova L, Buocikova V, Mego M, Cumova A, Burikova M, Bohac M . Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies. Biomed Pharmacother. 2024; 174:116559. DOI: 10.1016/j.biopha.2024.116559. View

3.
Zhao K, Jia C, Wang J, Shi W, Wang X, Song Y . Exosomal hsa-miR-151a-3p and hsa-miR-877-5p are potential novel biomarkers for predicting bone metastasis in lung cancer. Aging (Albany NY). 2024; 15(24):14864-14888. PMC: 10781484. DOI: 10.18632/aging.205314. View